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The initiation of neurogenic inﬂammation in pancreatitis is
unknown. This work shows that pancreatic acinar cells
express 5-lipoxygenase and produce leukotriene B4 (LTB4).
5-lipoxygenase inhibition reduces LTB4 secretion and
pancreatitis, indicating that LTB4 mediates neurogenic
pancreatic inﬂammation.
BACKGROUND & AIMS: In the pancreas, activation of primary
sensory nerves through the transient receptor potential
vanilloid-1 (TRPV1) ion channel contributes to the early stages
of development of pancreatitis. Little is known about the
mechanism by which this occurs. We investigated whether
leukotriene B4 (LTB4) is an endogenous agonist of TRPV1 and
mediates pancreatitis.
METHODS: Acute inﬂammation was induced in the pancreata
of Trpv1/ mice and their wild-type littermates by retrograde
infusion of the main pancreatic duct with 2% sodium taur-
ocholate (NaT) or intraperitoneal injections of caerulein. Mice
were also given injections of resiniferatoxin (an excitotoxin that
desensitizes TRPV1) or MK886 (a drug that inhibits LTB4
biosynthesis). Pancreatic tissues and plasma were collected and
analyzed.
RESULTS: Retrograde perfusion of the main pancreatic ducts of
wild-type mice with NaT caused severe acute pancreatitis; the
severity was reduced by coadministration of resiniferatoxin.
Trpv1/ mice developed a less severe pancreatitis after NaT
administration compared with controls. Administration of
MK886 before perfusion with NaT also signiﬁcantly reduced
the severity of pancreatitis in wild-type mice. Pancreatic tissues
from mice given NaT had a marked increase in the level of
5-lipoxygenase immunoreactivity speciﬁcally in acinar cells.
Bile acid and caerulein induced secretion of LTB4 by cultured
pancreatic acinar cells; MK886 inhibited this process.
CONCLUSIONS: Administration of caerulein or intraductal
bile acids in mice causes production of LTB4 by pancreatic
acinar cells. This activates TRPV1 on primary sensory nerves to
induce acute pancreatitis. (Cell Mol Gastroenterol Hepatol
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Institute. This is an open access article under the CC BY-NC-ND
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Inﬂammation; Secretagogue; Vanilloid.eurogenic inﬂammation is caused by the localNrelease of inﬂammatory neuropeptides such as
substance P and calcitonin gene-related peptide from
afferent sensory neurons. These peptides produce vasodila-
tion and edema and lead to neutrophil recruitment in the
affected tissue. In the pancreas, we have shown that activa-
tion of the transient receptor potential vanilloid-1 (TRPV1)
ion channel expressed by primary sensory nerves plays a role
in the inﬂammatory cascade in pancreatitis.1–5 We have
proposed that the respective inﬂammatory insults cause the
release of an endogenous TRPV1 agonist in the pancreas
resulting in TRPV1 activation in pancreatic primary sensory
nerves, which in turn release proinﬂammatory neurotrans-
mitters such as substance P6,7 both peripherally within the
pancreas itself to cause inﬂammation and centrallywithin the
spinal cord to cause pain.8,9 However, the endogenous ligand
that activates TRPV1 in pancreatitis is unknown. After the
cloning and molecular characterization of TRPV1, it was
discovered that leukotriene B4 (LTB4)
10 can activate this
receptor, raising the possibility that LTB4 could be the
endogenous ligand for TRPV1 after pancreatic injury. Despite
this possible role, there is very limited evidence that LTB4 is
found in the pancreas.
The mechanisms involved in the pathophysiology of
acute pancreatitis in humans are poorly understood. There
are multiple animal models of experimental acute pancrea-
titis, but the relevance of most of them to human pancreatitis
is unclear. One apparent exception is retrograde infusion of
bile acids into the main pancreatic duct in rats and mice.1–3
It has been proposed that this experimental model is closely
related to human biliary pancreatitis, which is thought to be
caused by bile reﬂux into the pancreatic duct secondary to
gallstone disease.4 There is evidence that acute pancreatitis
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of bile acids to a G protein-coupled receptor in the pancreatic
acinar cell apical plasma membrane. In this model, the
bile acid receptor G protein-coupled bile acid receptor-1
(Gpbar-1, also known as TGR5) when activated by binding
bile acids generates pathologic intracellular calcium tran-
sients, resulting in intra-acinar cell zymogen activation and
acinar cell injury.5
In the present study, we tested the hypothesis that the
mechanisms involved in acute pancreatitis induced by bile
acid or secretagogue hyperstimulation include generation of
an endogenous TRPV1 agonist that activates primary sen-
sory nerves to injure the pancreas. We found that bile acids
and caerulein hyperstimulation cause LTB4 synthesis and
secretion from pancreatic acinar cells and that this endog-
enous release of LTB4 activates TRPV1 to contribute to
acute pancreatitis.
Materials and Methods
These studies were approved by the Duke University
Institutional Animal Care and Use Committee.
Animals
Mice inwhich the Trpv1 gene has been deleted (Trpv1/)
were a kind gift of Dr. D. Julius, University of California–San
Francisco. Trpv1/ mice and wild-type littermates were
backcrossed onto a C57BL/6 background and genotyped as
described previously elsewhere.11
Materials
Sodium taurocholate (NaT), taurolithocholic acid 3-
sulfate disodium salt (TLCS), and resiniferatoxin (RTX)
were purchased from Sigma-Aldrich (St. Louis, MO), MK886
(1[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-a,a-
dimethyl-5-(1-methylethyl)-1H-indole-2-propanoic acid)
was purchased from Tocris Bioscience (Ellisville, MO), and
leukotriene B4 (LTB4) enzyme immunoassay kits were pur-
chased from Cayman Chemical (Ann Arbor, MI). Puriﬁed
mouse monoclonal anti-human 5-lipoxygenase (5-LO) pri-
mary antibody, biotinylated goat anti-mouse Ig secondary
antibody, and streptavidin-horseradish peroxidase were
purchased from BD Biosciences (San Jose, CA).
Induction of Acute Pancreatitis
Acute inﬂammation of the pancreas was stimulated by
retrograde infusion of the main pancreatic duct with 2% NaT
as described previously elsewhere.3,4 Brieﬂy, adult male wild-
type or Trpv1/ C57BL/6 mice were anesthetized by intra-
peritoneal injection of a mixture of 87.5% ketamine/12.5%
xylazine, and a midline laparotomy was used to expose the
ﬁrst portion of the duodenum. A puncturewoundwasmade in
the antimesenteric surface of the duodenum opposite the
ampulla ofVater, and a30Gcatheter attachedwith tubing toan
infusion pump was passed through the puncture wound and
then into the common bile duct via the ampulla of Vater. The
infusion catheter was secured in the distal common bile duct
distal to the entranceof thepancreatic ductwith a ligature, andthe bile duct near the liverwas occludedwith a bulldog clamp.
The inﬂammatory infusate consisted of 2% NaT in 0.9% NaCl
pumped into the pancreatic duct at a rate of 5 mL/min for 10
minutes with a syringe pump. Methylene blue (1%) was
included in the infusate to allow identiﬁcation of leakage from
the duct lumen. After 10 minutes, the catheter, ligature, and
bulldog clamp were removed, and the duodenotomy was
closed using a purse-string suture. The laparotomywas closed
in two layers, and analgesia was achieved by subcutaneous
injection of buprenorphine hydrochloride at a dose of 50 mg/
kg. The animalswere given free access to food andwater upon
recovery. The mice were killed 24 hours after surgery by CO2
asphyxiation and then were weighed. The pancreas was
removed andweighed; a portionwas frozen at80C for later
myeloperoxidase (MPO) assay, and a separate portion was
ﬁxed overnight at 4C in 10% formalin for the histopathologic
analysis. Mixed arteriovenous blood was also collected by
decapitation for serum amylase measurement.
Acute pancreatitis was also induced by secretagogue
hyperstimulation using 6 hourly subcutaneous injections of
caerulein at a dose of 50 mg/kg, as previously described
elsewhere.7,12 The mice were killed 1 hour after the last
caerulein injection by CO2 asphyxiation, and the tissues
collected as described previously.
The pharmacologic treatments tested for their ability to
inhibit NaT-induced acute pancreatitis included RTX, an
excitotoxin that desensitizes TRPV1 when used at high
concentrations,13 and MK886, a 5-lipoxygenase-activating
peptide (FLAP) inhibitor that inhibits LTB4 biosynthesis by
blocking 5-LO activity.14 RTX was dissolved in ethanol and
administered in 97.5% saline/2.5% ethanol either alone (in
control experiments) or together with 2% NaT in 0.9% NaCl
at a concentration of 14 mg/mL in the pancreatic ductal
infusate by retrograde infusion at 5 mL/min for 10 minutes.
RTX was given by intraductal infusion because this route of
delivery is effective in desensitizing TRPV1.15 The same RTX
dose was demonstrated to be efﬁcacious in inhibiting acute
pancreatitis in rats caused by pancreatic ductal infusion of
low pH endoscopic retrograde cholangiopancreatography
contrast solution.15 MK886 was administered as a pre-
treatment 1 hour before surgery by intraperitoneal injection
at a dose of 10 mg/kg dissolved in 2% ethanol/2% Tween
80/96% sterile 0.9% NaCl. Control mice were treated
similarly with the vehicle alone. This dose of MK886 has
previously been shown to inhibit pancreatic duct ligation-
induced acute pancreatitis in rats.16
Serum Amylase Activity
The serum amylase concentration was measured as
previously described elsewhere17 except that Phadebas
amylase test tablets (Magle Life Sciences, Cambridge, MA)
were used as substrate instead of Procion Yellow starch.
Myeloperoxidase Activity
We measured the tissue activity of MPO, an enzyme pro-
duced by neutrophils and used as a marker of inﬂammation
associatedwith neutrophil inﬁltration, as previously described
elsewhere using the substrate tetramethylbenzidine.18,19 The
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(Thermo Scientiﬁc, Rockford, IL).
Histopathology
Portions of the pancreata were ﬁxed overnight in
phosphate-buffered 10% formalin. The tissue was then
embedded in parafﬁn, sectioned at 5 mm, stained with H&E,
and coded for examination by two investigators blinded to
the experimental design. The severity of pancreatitis was
graded using a modiﬁed scoring criteria previously
described elsewhere.20
Leukotriene B4 Assay
Pancreatic LTB4 levels were measured by LTB4 enzyme
immunoassay kits purchased from Cayman Chemical. Brieﬂy,
samples of pancreas were collected in 5 volumes of ice-cold
0.1 M phosphate buffer, pH 7.4, containing 1 mmol/L EDTA
and 10 mmol/L indomethacin and were homogenized for
15 seconds on ice using a Polytron homogenizer (Brinkmann
Instruments, Westbury, NY) at a 60% power setting for
15 seconds. After homogenization, 2 volumes of ice-cold
ethanol were added to each extract, and the extracts were
then incubated on ice for 5 minutes to precipitate proteins.
After centrifugation at 3000gmax to remove the precipitated
proteins, the ethanol in the supernates was removed by
vacuum centrifugation. The pH of the extracts was adjusted
to w4.0 by addition of 1 M sodium acetate (pH 4.0). The
resulting precipitate was removed by centrifugation, and the
supernate was loaded onto C-18 solid phase extraction car-
tridges (Cayman Chemical) previously washed with meth-
anol and distilled water, washed with distilled water, and
then eluted at unit gravity with 5 mL of 99% ethyl acetate/
1% methanol. The samples were then evaporated to dryness
under a stream of nitrogen at 45C, reconstituted in LTB4
enzyme immunoassay buffer, and assayed according to the
instructions of the kit manufacturer.
Acinar cell LTB4 release in vitro was measured using the
supernate obtained after centrifuging suspensions of
pancreatic acini prepared as previously described else-
where,21 preincubated for 30 minutes at 37C, and incu-
bated with or without the bile acid TLCS (500 mmol/L) or
caerulein (100 pmol/L) for 30 minutes at 37C with con-
stant shaking in a water bath. When the effects of MK886
were tested, the acini were preincubated with 1 mmol/L
MK886 for 30 minutes at 37C, and then incubated with 1
mmol/L MK886 with or without TLCS for 30 minutes at
37C with constant shaking in a water bath.
5-Lipoxygenase Immunohistochemistry
Immunohistochemical staining for 5-LO was performed
as previously described elsewhere22 with minor modiﬁca-
tions. Portions of the head of the mouse pancreas were
taken 24 hours after duct infusion, ﬁxed overnight in 10%
buffered formalin at 4C, and embedded in parafﬁn; sections
5-mm thick were prepared and mounted on glass slides.
After deparafﬁnization and rehydration, antigen retrieval
was performed by incubating the sections in 10 mmol/L
citric acid (pH 6.0) in a microwave oven for 12 minutes (2minutes high power, 10 minutes low power). The slides
were then cooled to room temperature and washed in Tris-
buffered saline (TBS: 50 mmol/L Tris, 0.9% NaCl, pH 7.6).
Nonspeciﬁc staining was blocked by incubating the sections
in full-strength normal goat serum for 30 minutes at room
temperature. The sections were then incubated with the
monoclonal primary antibody (mouse anti-human 5-LO; BD
Biosciences) at a dilution of 1:500 in TBS–5% goat serum
overnight at 4C. After washing in TBS–5% goat serum, the
sections were incubated with biotinylated secondary anti-
body (goat anti-mouse Ig; BD Biosciences) at a dilution of
1:100 in TBS–5% goat serum for 1 hour at room tempera-
ture. Detection of the antibody complex was performed
using the streptavidin-horseradish peroxidase reaction with
diaminobenzidine as chromogen. Control sections were
treated identically except the primary antibody incubation
was omitted. All sections were counterstained with hema-
toxylin for 30 seconds at room temperature.
Human pancreas was obtained from patients at the time
of surgery for non-pancreas-involved conditions (controls)
and for complications of trauma-induced acute pancreatitis
and then treated as described previously. Samples were
secured through the Duke University School of Medicine
Biospecimen Repository and Processing Core (DUHS IRB
Pro00035974) as approved by the institutional reviewboard.
Quantitative Real-Time Polymerase
Chain Reaction
Total RNA from fresh pancreatic tissue was puriﬁed using
theRibopurekit (LifeTechnologies, Grand Island,NY) following
the manufacturer’s instructions. RNA (2 mg) was reverse tran-
scribed using High Capacity RNA-to-cDNA kits (Life Technolo-
gies), and polymerase chain reaction (PCR) was performed
using the Taqman gene expression master mix (Life Technol-
ogies) and Taqmangene expression assays for theAlox5 (5-LO)
and Actb (actin) genes (Life Technologies). Actb was the refer-
ence gene. Assays were performed in triplicate. The level of
expression was determined using the 2DDCt method.23
Western Blot Analysis
Tissue from the head of the pancreas obtained after
control or NaT treatment as described previously was sol-
ubilized on ice in a lysis buffer consisting of NaCl
(150 mmol/L), Tris, pH 7.5 (50 mmol/L), EDTA, pH 8.0
(10 mmol/L), dithiothreitol (1 mmol/L), Nonidet P-40 (1%
v/v), sodium deoxycholate (0.5% w/v), sodium dodecyl
sulfate (0.1% w/v), leupeptin (10 mg/mL), aprotinin
(10 mg/mL), one tablet of protease inhibitors (cOmplete-
Mini; Roche Diagnostics, Indianapolis, IN), and one tablet of
phosphatase inhibitor (PhossSTOP; Roche Diagnostics) per
7 mL of solution. Supernates (10 mg protein) were loaded
onto 4%–12% NuPage gels (Life Technologies), electro-
phoresed in 3-(N-morpholino)propanesulfonic acid buffer,
and transferred onto polyvinylidene diﬂuoride membranes
(PerkinElmer, Waltham, MA). Blots were ﬁrst reacted with a
mouse monoclonal anti-5-LO antibody (BD Biosciences) at a
dilution of 1/1000 and then with a rabbit polyclonal anti-a-
tubulin antibody (GeneTex, Irvine, CA) at a dilution of
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strate (Thermo Scientiﬁc).
Statistical Analysis
Results are expressed as mean ± standard error of the
mean (SEM). Mean differences between two groups were
examined by the Student t test and mean differences among
several groups by one-way analysis of variance with the
Dunnett’s or Tukey-Kramer posttests, using GraphPad
InStat version 3.05 for Windows (GraphPad Software, San
Diego, CA). P < .05 was considered statistically signiﬁcant.
Results
To determine whether infusion of NaT into the mouse
pancreatic duct causes pancreatitis, we examined several
features of acute pancreatitis 24 hours after instillation of50 mL of 2% NaT. As shown in Figure 1A, pancreatic his-
tology was markedly altered with distortion of acini, in-
ﬂammatory cell inﬁltration, and tissue necrosis. Changes in
speciﬁc anatomic and biochemical parameters conﬁrmed
the development of pancreatitis and were consistent with
the observed histologic changes. The NaT treatment pro-
duced a signiﬁcant increase in the plasma concentration of
amylase 24 hours after infusion, consistent with the induc-
tion of pancreatic injury (Figure 1C). An increase in
pancreatic edema, a feature common to many types of acute
pancreatitis and typical of neurogenic inﬂammation, also
was observed in NaT-treated mice as indicated by the
elevated ratio of the wet weight of the pancreas to total
body weight (Figure 1D). Finally, consistent with the ﬁnding
of inﬂammatory cells in the pancreas after NaT treatment,
there was a marked increase in MPO concentrations
(Figure 1E). MPO is highly expressed in neutrophils and isFigure 1. Intrapancreatic
duct infusion of bile acids
causes pancreatitis. The
effects of pancreatic duct
infusion of 50 mL of 2%NaT
on pancreatic histopathol-
ogy, serum amylase levels,
pancreatic edema, and
pancreatic MPO levels are
shown (n ¼ 6). (A) The ef-
fects of pancreatic duct
infusion with 2% NaT on
pancreatic histology. (B)
The effects of NaT on his-
topathology score (****P <
.0001 vs control). (C) The
effects of NaT on serum
amylase levels (***P < .001
vs control). (D) The effects
of NaT on pancreatic
edema (**P < .01 vs con-
trol). (E) The effects of NaT
on pancreatic MPO levels
(****P < .0001 vs control).
Scale bar ¼ 100 mm.
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inﬁltration. Together, these data indicate that bile duct
infusion of NaT induces acute pancreatitis.
We previously reported that neurogenic inﬂammation
contributes to the pathogenesis of pancreatitis produced by
secretagogue hyperstimulation.7,12 Moreover, the manifes-
tation of this inﬂammation requires the activation of the
vanilloid receptor TRPV1. To determine whether bile acids
induce neurogenic pancreatitis, we used two methods to
examine the role of TRPV1. First, to determine whether
TRPV1 mediates some or all of pancreatic edema induced by
bile acid, the effect of adding a desensitizing dose of the
TRPV1 excitotoxin RTX to NaT in the pancreatic duct infu-
sate was tested. As shown in Figure 2, when RTX was
coinfused with NaT, there was a marked improvement in theFigure 2. The effects of RTX desensitization of TRPV1 in pan
RTX was infused into the pancreatic duct of wild-type mice (n ¼
pancreatic histology and the protective effect of coinfusion of R
score, expressed as a percentage of the control value (***P < .0
amylase, expressed as a percentage of the control value (*P
pancreatic edema, expressed as a percentage of the control valu
pancreatic MPO concentration, expressed as a percentage of thistologic features of pancreatitis compared with NaT
administration alone. RTX also signiﬁcantly reduced blood
amylase levels and pancreatic edema over control levels.
Notably, duct infusion with RTX alone had no effect on
pancreatic edema. Consistent with the lower numbers of
inﬂammatory cells seen in histologic sections of the
pancreas, the addition of RTX to the NaT infusion resulted in
much lower MPO levels in the pancreas than seen with NaT
administration alone.
The second method for evaluating the role of TRPV1 in
pancreatitis induced by bile acid was to test the effects of
NaT administration in mice with genetic deletion of TRPV1.
Trpv1/ mice treated with NaT did not develop the histo-
logic features typical of acute pancreatitis (Figure 3). The
histologic scoring parameters and pancreatic MPO levelscreatitis induced by bile acid. NaT with or without 14 mg/mL
6). (A) The effects of pancreatic duct infusion with 2% NaT on
TX. (B) The effects of NaT and NaT þ RTX on histopathology
01 vs NaT). (C) The effects of NaT and NaT þ RTX on serum
< .05 vs NaT). (D) The effects of NaT and NaT þ RTX on
e (**P < .01 vs NaT). (E) The effects of NaT and NaT þ RTX on
he control value (****P < .0001 vs NaT). Scale bar ¼ 100 mm.
Figure 3. The effects of intraductal NaT in Trpv1L/L mice. NaT was infused into the pancreatic duct of Trpv1/ mice
(N ¼ 6). (A) The effects of pancreatic duct infusion with 2% NaT on pancreatic histology in wild-type and Trpv1/mice. (B) The
effects of NaT on histopathology score in wild-type and Trpv1/ mice, expressed as a percentage of the control value
(***P< .001 vs NaT) (C) The effects of NaT on serum amylase in wild-type and Trpv1/mice, expressed as a percentage of the
control value (*P < .05 vs NaT). (D) The effects of NaT on pancreatic edema in wild-type and Trpv1/ mice, expressed as a
percentage of the control value. (E) The effects of NaT on pancreatic MPO concentration in wild-type and Trpv1/ mice,
expressed as a percentage of the control value (***P < .001 vs NaT). Scale bar ¼ 100 mm.
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levels were not lower in Trpv1/ mice, suggesting to us
that bile acids may injure acinar cells directly or affect
pancreatic release of amylase, as we had observed previ-
ously in the secretagogue hyperstimulation model.7 How-
ever, this process does not appear to involve TRPV1 and
does not cause pancreatitis in Trpv1/ mice. Taken
together, it appears that both pharmacologic blockade of
TRPV1 with RTX and genetic deletion of TRPV1 protect
against pancreatitis induced by bile acid.
Leukotriene B4 can activate TRPV1,
10 and we previously
reported that LTB4 infusion into the pancreas can induce
pancreatic inﬂammation.16 We next sought to determine
whether bile acids stimulate pancreatic LTB4 synthesis. Toaddress this question, we measured the concentration of
LTB4 in pancreatic extracts 24 hours after duct infusion of
NaT or 1 hour after caerulein hyperstimulation. As shown in
Figure 4A, NaT and caerulein (inset) stimulated highly sig-
niﬁcant increases in pancreatic LTB4 content compared with
controls. The rate-limiting enzyme in the biosynthesis of
LTB4 is 5-LO. The cofactor FLAP is necessary for the
biosynthesis to occur. Thus, inhibition of FLAP prevents
LTB4 formation. We observed that pretreatment of the NaT-
treated animals with the FLAP inhibitor MK886 signiﬁcantly
reduced pancreatic LTB4 levels (Figure 4A).
Next, we tested the ability of pancreatic acini to secrete
LTB4 in response to bile acid or caerulein in vitro to conﬁrm
that acinar cells are the source of LTB4 in the pancreas and to
Figure 4. Bile acids stimulate LTB4 formation in the
pancreas. (A) Effect of pancreatic duct infusion of NaT on
LTB4 concentrations in the head of the pancreas in vivo and
inhibition of the NaT-stimulated increase in pancreatic LTB4
levels by pretreatment with 1 mmol/L MK886, a FLAP inhibitor
(n ¼ 6; ***P < .001 vs control; ##P < .01 vs NaT). Inset: The
effect of caerulein hyperstimulation on LTB4 concentrations in
the head of the pancreas in vivo (n¼ 6; ***P< .001 vs control).
(B) Effect of TLCS on LTB4 secretion from wild-type mouse
pancreatic acini in vitro. TLCS (500 mmol/L) signiﬁcantly
stimulated LTB4 secretion from pancreatic acini (n ¼ 5–9;
**P < .01 vs control) and this effect was signiﬁcantly inhibited
by 1 mmol/L MK886 (#P< .05 vs TLCS alone). Inset: The effect
of caerulein hyperstimulation (100 pmol/L) on LTB4 secretion
from pancreatic acini (n ¼ 6; **P < .01 vs control). LTB4 levels
were normalized to pancreatic protein concentrations and
expressed as a percentage of the control values.
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LTB4 secretion from acinar cells. We used the bile acid TLCS
instead of NaT in these experiments for the following rea-
sons: previous observations had indicated that NaT in con-
centrations as low as 0.2% causes nonspeciﬁc acinar cell
injury in vitro,3 and TLCS, a naturally occurring bile acid in
mice and humans, had been shown to cause acinar cell injuryat concentrations below detergent-like or ionophore-like ef-
fects and below pathologic relevance.5,24 Incubation of
pancreatic acini from wild-type mice with 500 mmol/L TLCS
for 30 minutes in vitro stimulated a 3-fold increase in LTB4
secretion over basal levels (P < .001; Figure 4B); caerulein
hyperstimulation had the same effect (inset). TLCS at the
nondamaging concentration of 100 mmol/L did not cause a
signiﬁcant increase in LTB4 secretion. Notably the FLAP in-
hibitor MK886 signiﬁcantly inhibited TLCS-stimulated LTB4
synthesis, demonstrating that pancreatic acinar cells also
synthesize LTB4 in response to bile acids.
These results raised the question of the provenance of
LTB4 in the pancreas. Leukocytes are known to be a rich
source of 5-LO and LTB4,
14 and it is well known that acute
pancreatitis exhibits increased neutrophil inﬁltration into the
pancreas. However, a parenchymal origin of LTB4 could bet-
ter account for the inhibition of acute pancreatitis by TRPV1
blockade that we observed because of the close proximity of
acinar cells to nerve endings. Therefore, we sought to deter-
mine the source of LTB4 using immunohistochemistry for
5-LO, the rate-limiting enzyme in LTB4 biosynthesis.
14
Very little immunoreactive 5-LO was observed in the
pancreas of control mice whose pancreatic ducts were
perfused with the saline vehicle (Figure 5A). In contrast,
retrograde pancreatic duct infusion with the bile acid NaT
caused intense 5-LO immunostaining in acinar cells and a
marked increase in the number of acinar cells showing 5-LO
immunoreactivity (Figure 5A). The pancreatic ducts exhibi-
ted little immunoreactivity, but islets appeared to express
small amounts of 5-LO. In bile acid–treated animals, 5-LO
immunoreactivity was most prominent in the basal poles of
the acinar cells, consistent with the distribution of rough
endoplasmic reticulum (rER). A similar 5-LO immunostaining
pattern was observed when the pancreata of NaT-treated
Trpv1/ mice were analyzed (Figure 5A). This result indi-
cated that bile acid–stimulated LTB4 activation is proximal to
TRPV1 stimulation in the inﬂammatory mechanism. Inter-
estingly, when wild-type mice were pretreated with MK886
before the NaT perfusion, 5-LO immunostaining in the
pancreas was abolished (Figure 5A), indicating that FLAP
activity is required both for inﬂammation induced by bile acid
and for increased 5-LO immunoreactivity in the pancreas.
The increased 5-LO immunoreactivity that accompanied
acute pancreatitis led us to ask whether increased 5-LO
expression accounted for this observation. Quantitative
real-time PCR analysis revealed that there was no signiﬁcant
difference in Alox5 (5-LO) mRNA expression between the
pancreases of control and NaT-treated mice (Figure 5B).
Similarly, Western blot analysis showed no signiﬁcant dif-
ference in pancreatic 5-LO protein levels between control
and bile acid–treated mice (Figure 5C and D).
To determine whether 5-LO activation was relevant to
human pancreatitis, we performed 5-LO immunohisto-
chemical staining in pancreas of patients who underwent
surgery for nonpancreatic conditions (controls) and for
acute pancreatitis. Similar to the ﬁndings we observed in
mice, 5-LO immunoreactivity was very low in control pa-
tients (Figure 5E) but was prominently expressed in the
inﬂamed pancreas from a patient with acute pancreatitis
Figure 5. Bile acids regulate 5-lipoxygenase immunoreactivity in the mouse pancreas. (A) Photomicrographs of sections
taken from the head of the mouse pancreas and stained immunohistochemically for 5-LO. Pancreatic duct infusion with
vehicle (control) in wild-type mice resulted in little 5-LO immunoreactivity. Pancreatic duct infusion with NaT in wild-type mice
(magniﬁcation 200) elicited increased 5-LO immunoreactivity seen mainly in acinar cells localized mainly in the basal poles of
the cells as seen at magniﬁcation 400. Pancreatic duct infusion with NaT in Trpv1/ mice caused a similar pattern of 5-LO
expression as seen in wild-type mice. Pancreatic duct infusion with NaT after pretreatment with MK886 in wild-type mice
resulted in the virtual abolition of 5-LO immunoreactivity. (B) The effects of NaT on 5-LO mRNA. The pancreatic ducts of wild-
type mice were retrogradely infused with vehicle (control) or NaT, and 24 hours later portions of the head of the pancreas were
separately collected. RNA was puriﬁed from one portion and reverse transcribed to cDNA, and the Alox5 gene (5-LO) was
assessed by quantitative real-time PCR. There was no signiﬁcant difference in the levels of 5-LO RNA in control versus NaT-
treated sample. (C) Western blots showed that NaT did not affect the level of 5-LO protein expression in the head of the
pancreas, and (D) densitometric analysis of the immunoblot conﬁrmed the lack of signiﬁcant differences. (E and F) The effect of
acute pancreatitis on 5-LO immunoreactivity in the human pancreas: (E) control and (F) acute pancreatitis. Human acute
pancreatitis patients showed a pattern of increased 5-LO immunoreactivity similar to that seen in mice. Scale bars ¼ 50 mm.
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intense at the basal poles of acinar cells where rER is
abundant (Figure 5F).
Finally, to determine whether endogenous LTB4 syn-
thesis is critical for the genesis of pancreatitis, we tested the
effects of the FLAP inhibitor MK886 on NaT-induced
pancreatitis in vivo. As shown in Figure 6, MK886 pre-
treatment reduced the severity of NaT-induced histologic
changes, blood amylase levels, pancreatic edema, and MPO
levels. These changes of reduced pancreatitis severity are
similar to those observed in RTX-treated wild-type and
Trpv1/ mice, supporting the concept that recently syn-
thesized LTB4 mediates bile acid–induced pancreatitis.Discussion
The present results demonstrate that acinar cell secretion
of LTB4 plays an important role in acute pancreatitis induced
by bile acid or caerulein hyperstimulation. This is consistentwith previous studies implicating LTB4 in experimental acute
pancreatitis, such as the demonstrations that intraductal NaT
in rats elicited increased pancreatic levels of LTB4,
25–27
pharmacologic inhibition of 5-LO in the same rat model
protected against histologic pancreatic damage,28 genetic
deletion of 5-LO inhibited acute pancreatitis in the caerulein
hyperstimulation model in mice,29 and a dual COX-2/5-LO
pharmacologic inhibitor protected rats against caerulein
hyperstimulation-induced pancreatic inﬂammation.30 How-
ever, the cellular source of LTB4 and themechanism bywhich
it induces acute pancreatitis was not revealed in those
studies. We show here that pancreatic acinar cells are the
source of LTB4 released in response to pancreatitis induced
by bile acid or caerulein hyperstimulation, and that this LTB4
activates TRPV1 to cause inﬂammation.
We ﬁrst demonstrated that desensitization of TRPV1
using the TRPV1 excitotoxin RTX resulted in signiﬁcant
inhibition of several indices of NaT-induced pancreatitis,
including pancreatic histopathology, serum amylase
Figure 6. Bile acid–induced pancreatitis requires 5-LO activation. Wild-type mice were pretreated with the FLAP inhibitor
MK886 before intrapancreatic duct infusion of NaT (n ¼ 6–7). (A) The effects of pancreatic duct infusion with 2% NaT on
pancreatic histology and the protective effects of pretreatment with 10 mg/kg MK886 on pancreatic histology. (B) The effects of
NaT and NaTþMK886 on histopathology score, expressed as a percentage of the control value (****P < .0001 vs NaT). (C) The
effects of NaT and NaTþMK886 on serum amylase, expressed as a percentage of the control value. (D) The effects of NaT and
NaTþMK886 on pancreatic edema, expressed as a percentage of the control value (*P< .05 vs NaT). (E) The effects of NaT and
NaT þ MK886 on pancreatic MPO concentration, expressed as a percentage of the control value (***P < .001 vs NaT).
January 2015 LTB4 in Pancreatitis 83concentrations, pancreatic edema, and pancreatic MPO
levels. TRPV1 gene deletion signiﬁcantly inhibited pancreatic
histopathology and MPO levels but had no effect on pancre-
atic edema. In addition, TRPV1 gene deletion did not inhibit
the NaT-induced elevation of serum amylase concentrations,
suggesting that this effect of NaT is a direct one on pancreatic
acinar cells that does not involve proinﬂammatory neuro-
transmitter release secondary to TRPV1 activation, although
some other pathway involving a TRPV1-expressing cell type
may be involved because RTX treatment, which causes
desensitization or loss of TRPV1-expressing cells, did signif-
icantly reduce NaT-induced edema. These results taken
together indicated that NaT causes the release of an endog-
enous TRPV1 agonist ligand in the pancreas.
We had previously demonstrated that TRPV1 plays a
role in acute experimental pancreatitis in several otherexperimental models, such as secretagogue hyperstimula-
tion,7,12,31 ligation of the common pancreaticobiliary
duct,12,16 and retrograde perfusion of the pancreatic duct
by endoscopic retrograde cholangiopancreatography
contrast medium.15 In these models, we proposed that the
respective inﬂammatory insults cause the release of an
endogenous TRPV1 agonist in the pancreas, resulting in
TRPV1 activation in pancreatic primary sensory nerves,
which in turn release proinﬂammatory neurotransmitters
such as substance P6,7 both peripherally within the
pancreas itself to cause inﬂammation and centrally within
the spinal cord to cause pain.8,9 We provided evidence in
the duct ligation model of pancreatitis that the endogenous
TRPV1 agonist LTB4
10 could be an endogenous TRPV1
activator generated by the inﬂammatory insult to the
tissue.16
Figure 7. A model depicting the mechanisms by which intraductal bile acids cause acute pancreatitis in the mouse. Bile
acids bind to the bile acid receptor Gpbar1 expressed on the apical plasma membranes of acinar cells.5 This interaction
causes increased 5-LO activity in the acinar cell, resulting subsequently in LTB4 synthesis and secretion from the cell.
Increased pancreatic LTB4 concentrations can then bind to TRPV1 receptors expressed by a subclass of primary sensory
afferent nerves innervating the pancreas, resulting in the peripheral release of proinﬂammatory neurotransmitters such as
substance P, which subsequently causes neutrophil recruitment, edema and necrosis, and acute pancreatitis.
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esis that NaT stimulates LTB4 release in the pancreas. First,
we showed that pharmacologic inhibition of FLAP by pre-
treatment with the drug MK886 inhibits NaT-induced
pancreatic inﬂammation. FLAP is an essential cofactor for
5-LO activity (the rate-limiting enzyme in LTB4 biosyn-
thesis14). MK886 has been shown to inhibit peroxisome
proliferator-activated receptor a (PPARa) as well as FLAP,32
but PPARa inhibition cannot explain the present ﬁndings
because activation of PPARa has been shown to reduce
pancreatic injury in experimental pancreatitis.33 Thus, a
drug inhibiting PPARa such as MK886 would be expected to
enhance pancreatitis instead of reducing it, as occurred in
our study. Second, we showed directly that intraductal NaT
administration caused an increase in pancreatic levels of
LTB4 and that this effect was inhibited by pretreatment with
MK886. These results suggest that intraductal NaT activates
5-LO in the pancreas, resulting in local production of LTB4
and subsequent activation of TRPV1.
However, none of the previous studies had indicated the
cellular source of 5-LO, so where LTB4 was actually pro-
duced remained to be determined. Very little is known
about leukotriene production in the pancreas. It was pre-
viously been shown by others that porcine34 and human22
pancreatic acinar cells express 5-LO and can synthesize
LTB4. In addition, the human pancreas also expresses
FLAP,35 but no information was available about the distri-
bution of 5-LO in the mouse pancreas or the effects of
inﬂammatory agents on pancreatic 5-LO activity.We performed immunohistochemical analysis for 5-LO in
ﬁxed sections of mouse pancreas prepared from the various
experimental groups and found that very little 5-LO immu-
noreactivity was detectable in control animals in which the
pancreatic duct was infusedwith the saline vehicle. When the
duct was infused with NaT, however, a dramatic increase in
immunoreactive 5-LO was clearly observable in acinar cells.
The immunoreactive 5-LO in acinar cells was mostly seen in
the basal poles of the cells, consistent with the localization of
rER. Islets of Langerhans and pancreatic ducts exhibited little
if any 5-LO immunoreactivity, and no differences were seen
between vehicle-treated and NaT-treated animals in these
parts of the pancreas. Interestingly, when 5-LO immuno-
staining was performed in Trpv1/ mice treated with NaT,
the same pattern of acinar cell staining was seen, supporting
the concept that LTB4 generation precedes TRPV1 activation
in this model. In addition, pretreatment of the mice with the
FLAP inhibitor MK886 completely abolished 5-LO immuno-
staining in the acinar cells, suggesting that active FLAP is
required for both 5-LO immunostaining and for 5-LO catalytic
activity as demonstrated herein.
The most extensively studied cells expressing 5-LO in
mammals are leukocytes.36 In leukocytes, it has been sug-
gested that translocation of 5-LO from a soluble cell
compartment to an intracellular membrane compartment
such as rER or nuclear membrane is required for enzymatic
activity36 and that the FLAP inhibitor MK886 blocks this
translocation.37 However, it has also been shown in human
alveolar macrophages that FLAP is not involved in the
January 2015 LTB4 in Pancreatitis 85translocation of 5-LO to the nuclear envelope,38 suggesting
that the elimination of 5-LO immunostaining by MK886 pre-
treatment in our studies may be explained by some other
nontranslocation mechanism. Whatever the mechanism
involved, it does not appear that changes in 5-LO gene or
protein expression can account for this effect on 5-LO immu-
noreactivity because PCR and Western blot analyses showed
no changes in 5-LO expression after bile acid treatment.
Demonstrating the ability of pancreatic acinar cells to
synthesize and secrete LTB4 and showing that bile acid
treatment increasespancreatic LTB4 levelsdoesnotprove that
acinar cells are the source of the increase stimulated by bile
acid because there are other sources of LTB4 in the pancreas,
including, most notably, leukocytes such as neutrophils and
macrophages. Therefore, we tested the response of pancreatic
acinar cells in vitro, in the form of isolated pancreatic acini, to
bile acid and caerulein stimulation. In this experiment, we
used the natural bile acid TLCS to compare our results to those
of others who have used this compound to investigate other
aspects of bile acid–induced pancreatitis. In those previous
studies, it was shown that TLCS at a concentration of 500
mmol/L causes unphysiologic cytoplasmic calcium release
patterns and subsequent acinar cell necrosis whereas TLCS at
100 mmol/L does not.5,24,39 We found that 500 mmol/L TLCS
and100pmol/L caerulein caused signiﬁcant increases in LTB4
secretion from acini in vitro whereas TLCS at a concentration
of 100 mmol/L did not. This is consistent with the concept that
the bile acid–induced increase in pancreatic LTB4 secretion
that results in acute inﬂammation via TRPV1 activation occurs
at the level of acinar cells.
The effectiveness of MK886 to prevent neutrophil inﬁl-
tration indicates that 5-LO activation and LTB4 synthesis is
an early event in triggering pancreatitis and precedes
neutrophil recruitment. However, our data do not exclude
the possibility that additional LTB4 could be produced by
neutrophils recruited to the pancreas later in the course of
disease. Should this occur, additional LTB4 could contribute
to the inﬂammatory response in a feed-forward manner.
MK886 treatment effectively inhibited pancreatitis and
appeared to improve some biochemical and histologic pa-
rameters of pancreatitis (eg, edema) to a greater extent than
TRPV1 gene deletion. The reason that FLAP inhibition was
more effective than TRPV1 inhibition is not known but may
be explained by actions of LTB4 on its own cognate BLT-1 or
-2 receptors.
It has previously been shown that mouse pancreatic
acinar cells express a G protein-coupled bile acid receptor
termed Gpbar1 on their apical plasma membranes that may
mediate the inﬂammatory effects of bile acids.5 These re-
ceptors are coupled to the cytoplasmic calcium changes that
result in acinar cell injury in response to inﬂammatory con-
centrations of bile acids such as TLCS.5,40,41 Coupled with the
fact that increases in intracellular calcium concentrations are
known to be involved in activation of 5-LO,36 this suggests
that the inﬂammatory effects of bile acids produced in acute
inﬂammation may be mediated by activation of Gpbar1,
resulting in increased 5-LO activity and LTB4 secretion and
subsequent TRPV1 stimulation of neurogenic inﬂammation.
However, in preliminary studies we showed that, whereasincreased intracellular Caþþ concentrations can elicit acinar
cell LTB4 secretion, bile acid–induced LTB4 secretion is Ca
þþ-
independent and instead is the result of increased tyrosine
kinase activity resulting in activation of extracellular signal-
regulated kinases 1/2 (ERK1/2).42
In summary, we have presented evidence that the in-
ﬂammatory effects of NaT infused retrogradely into the
pancreatic duct are mediated by generation of LTB4 in
acinar cells and subsequent LTB4 activation of TRPV1 in
primary sensory neurons (Figure 7). This pathway may be
common to other causes of pancreatitis that activate intra-
pancreatic 5-LO. This pathophysiologic mechanism provides
a conceptual basis for the potential treatment of pancreatic
inﬂammatory diseases by inhibition of this pathway.References
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